• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Delaware Healthcare Fund

+ Add to Watchlist

DLHIX:US

19.63 USD 0.02 0.10%

As of 09:29:30 ET on 12/19/2014.

Snapshot for Delaware Healthcare Fund (DLHIX)

Year To Date: +20.38% 3-Month: +2.91% 3-Year: +31.88% 52-Week Range: 16.10 - 19.66
1-Month: +1.71% 1-Year: +23.45% 5-Year: +21.38% Beta vs RGUSH: 0.93

Mutual Fund Chart for DLHIX

No chart data available.
  • DLHIX:US 19.63
  • 1M
  • 1Y
Interactive DLHIX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DLHIX

Delaware Healthcare Fund is an open-end fund incorporated in the USA. The Fund's objective is to maximize long-term capital growth through capital appreciation. The Fund invests at least 80% of its assets in the equity securities of health care companies.

Inception Date: 09-28-2007 Telephone: 1-800-523-1918
Managers: LIU-ER CHEN "NU"
Web Site: www.delawareinvestments.com/co/delaware

Fundamentals for DLHIX

NAV (on 2014-12-19) 19.63
Assets (M) (on 2014-12-19) 458.06
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for DLHIX

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-12-05) 0.06
Dividend Yield (ttm) 10.87

Fees & Expenses for DLHIX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.85
Redemption Fee 0.00
12b1 Fee 0.00
Expense Ratio 1.10

Top Fund Holdings for DLHIX

Filing Date: 10/31/2014
Name Position Value % of Total
Eli Lilly & Co 600,000 39,798,000 8.813%
Teva Pharmaceutical Industries 513,000 28,969,110 6.415%
Pfizer Inc 800,000 23,960,000 5.306%
UCB SA 249,785 20,143,441 4.461%
Bristol-Myers Squibb Co 341,737 19,885,676 4.404%
Chugai Pharmaceutical Co Ltd 600,000 18,764,324 4.155%
GlaxoSmithKline PLC 400,000 18,196,000 4.029%
Fresenius Medical Care AG & Co 230,000 16,880,804 3.738%
Boston Scientific Corp 1,100,000 14,608,000 3.235%
Quest Diagnostics Inc 220,000 13,961,200 3.092%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil